A Case of Moderate Hidradenitis Suppurativa and Psoriasis Treated with Secukinumab.
- Author:
Pistone GIUSEPPE
1
;
Pardo NICOLA
;
Caputo VALENTINA
;
Castelli ELENA
;
Curiale SALVATRICE
;
Gurreri ROSARIO
;
Bongiorno Maria RITA
Author Information
- Publication Type:Case Report
- Keywords: Hidradenitis suppurativa; Interleukin-17; Psoriasis
- MeSH: Antibodies; Apocrine Glands; Hidradenitis Suppurativa*; Hidradenitis*; Humans; Inflammation; Interleukin-17; Interleukins; Psoriasis*; Recurrence; Th17 Cells
- From:Annals of Dermatology 2018;30(4):462-464
- CountryRepublic of Korea
- Language:English
- Abstract: Hidradenitis suppurativa (HS) is a disorder of the apocrine gland causing a chronic, recurrent and painful inflammation. It is a disabilitating condition and, though many therapeutic options are available, the response is often ineffective in most cases and patients can present many recurrences with physical and psychological sequelae. Recent data had shown increased interleukin (IL)-17 serum levels in patients with HS. Psoriasis is a chronic immune-mediated inflammatory disorder and new evidences have shown the role of Th17 cells in its pathogenesis and the therapeutic efficacy of anti-IL-17 antibodies. We present a case of a patient suffering from psoriasis and HS successfully treated with anti-IL-17 antibodies for both conditions. This is the first case report of HS treated with secukinumab.
